In this heterologous suppression assay, the regulatory activity exerted by CD4+CD25low/-GITR+ cells from SLE patients resulted higher than CD4+CD25highGITR− cells from SLE patients as already demonstrated in autologous suppression tests (Figure 5). This evidence concerns the gene TNFRSF18 and systemic lupus erythematosus.